Perspective Therapeutics (CATX) Debt to Equity (2023 - 2026)

Perspective Therapeutics recorded quarterly Debt to Equity of $0.0 in Q1 2026, down 40.98% quarter-over-quarter from $0.01 in Q4 2025, and down 20.97% year-over-year from $0.01 in Q1 2025.

Perspective Therapeutics' Debt to Equity history runs 4 years deep, the most recent figure standing at $0.0 for Q1 2026.

  • In Q1 2026, Debt to Equity fell 20.97% year-over-year to $0.0; the TTM figure through Mar 2026 stood at $0.0 (down 20.97% YoY), while the FY2025 annual figure was $0.01, up 35.56% from the prior year.
  • Debt to Equity came in at $0.0 for Q1 2026 at Perspective Therapeutics, down from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.02 in Q4 2023 to a low of $0.0 in Q1 2026.
  • A 4-year average of $0.01 and a median of $0.01 in 2025 frame the typical range for Debt to Equity.
  • Across the five-year window, Debt to Equity slumped 74.92% in 2024 and jumped 35.56% in 2025, its largest moves.
  • Perspective Therapeutics' Debt to Equity stood at $0.02 in 2023, then tumbled by 74.92% to $0.01 in 2024, then soared by 35.56% to $0.01 in 2025, then tumbled by 40.98% to $0.0 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods registered $0.0, $0.01, and $0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - 0.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.01
Dec 31, 2023 0.02
Sep 30, 2023 0.02
Jun 30, 2023 0.02
Mar 31, 2023 0.01